Discover our new oral solid dose (OSD) development capabilities at our Bend, Oregon site.
Patheon’s Kaspar Van den Dries sits down with Pharmaceutical Technology Magazine to discuss which crucial characteristics you should look for when researching and selecting a solubility enhancement vendor.
Author:
Kaspar Van den Dries,
Senior Director Formulation Sciences